EUVIMEDTutustu EUVIMEDiin
Open access · CC BY 4.0

The p. Ser143Pro lamin A/C mutation leads to dilated cardiomyopathy and activates the unfolded protein response pathway in a knock‐in mouse model

Fanny Lindholm iD, Gun West iD, Laura Virtanen iD, Laura Kähäri iD, Mia Ståhle iD, Wail Nammas iD, Carl-Gustaf A Stenvall iD, Maria Bouvy-Liivrand iD, Fu-Ping Zhang iD, Petra Sipilä iD, Maria Gardberg iD, Diana M Toivola iD and 4 more

The Journal of Pathology · 2026-11-14

DOI: 10.1002/path.70150 ↗

At a glance

Journal article in The Journal of Pathology, published online on 2026-11-14. Written by Fanny Lindholm and 15 co-authors. Institution: Institute of Biomedicine, University of Turku, Turku, Finland. 40 references. The full text is freely available (open access, CC BY 4.0). Funded by: Research Council of Finland, Sigrid Jusélius Foundation, Finnish Foundation for Cardiovascular Research.

TiivistelmäSubjectsBibliografiset tiedotCiteRelated studies

Abstract (original language)

Dilated cardiomyopathy (DCM) is characterized by progressive ventricular dilation, systolic dysfunction, and an increased risk of arrythmias and sudden cardiac arrest. Variants in the LMNA gene, which encodes the nuclear lamins A and C, have been linked to the familial form of the disease and the founder variant p.Ser143Pro is particularly common among Finnish patients with DCM. To elucidate the complex and poorly understood pathogenic mechanisms behind LMNA ‐related DCM, we generated a mouse model carrying the p.Ser143Pro mutation in the Lmna gene. All genetically modified mice appeared normal at birth. However, based on echocardiography, necropsy, natriuretic peptide B ( Nppb ) expression levels, and histopathological data, homozygous males developed progressive left ventricular dilatation, myocardial fibrosis, and cardiac failure after 6 months of age, with all succumbing before 10 months. A reduced disease penetrance was observed in heterozygous male and homozygous female mice, with one‐year survival rates of 40% and 60%, respectively. No signs of skeletal myopathy were observed in mice carrying the mutation. Whole‐transcriptome RNA sequencing analysis of left ventricular cardiac tissue from asymptomatic two‐month‐old homozygous male mice revealed an upregulation of classical heart failure markers, such as natriuretic peptide A ( Nppa ) and myosin heavy chain 7 ( Myh7 ), and an elevated unfolded protein response signaling, as shown by elevated DNA damage inducible transcript 3 ( Ddit3 ), BAG cochaperone 3 ( Bag3 ) and CCAAT enhancer binding protein beta ( Cebpb ) levels. In conclusion, p.Ser143Pro‐ Lmna mice closely mimic the clinical phenotype observed in patients with the p.Ser143Pro LMNA variant and offer a valuable in vivo model for investigating the underlying pathogenic mechanisms of LMNA ‐related DCM. © 2026 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Subjects

Author keywords

LMNALamin A/Cdilated cardiomyopathyknock‐in mouse modelleft ventricular systolic dysfunctionunfolded protein responsewhole‐transcriptome RNA‐seq

Authors and institutions

  • Institute of Biomedicine, University of Turku, Turku, Finland.
  • InFLAMES Flagship, University of Turku and Åbo Akademi University, Turku, Finland.
  • Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland.
  • Turku Collegium for Science, Medicine and Technology, University of Turku, Turku, Finland.
  • Cell Biology, Biosciences, Faculty of Science and Engineering, Åbo Akademi University, Turku, Finland.
  • Genevia Technologies, Tampere, Finland.

ORCID profiles: Fanny Lindholm, Gun West, Laura Virtanen, Laura Kähäri, Mia Ståhle, Wail Nammas, Carl-Gustaf A Stenvall, Maria Bouvy-Liivrand, Fu-Ping Zhang, Petra Sipilä, Maria Gardberg, Diana M Toivola, Marko Salmi, Antti Saraste, Petteri Rinne, Pekka Taimen

Funding

  • Research Council of Finland
  • Sigrid Jusélius Foundation
  • Finnish Foundation for Cardiovascular Research
  • Sigrid Juséliuksen Säätiö
  • Sydäntutkimussäätiö

Cite

APA

Lindholm, F., West, G., Virtanen, L., Kähäri, L., Ståhle, M., Nammas, W., Stenvall, C. A., Bouvy-Liivrand, M., Zhang, F. P., Sipilä, P., Gardberg, M., Toivola, D. M., Salmi, M., Saraste, A., Rinne, P., & Taimen, P. (2026). The p. Ser143Pro lamin A/C mutation leads to dilated cardiomyopathy and activates the unfolded protein response pathway in a knock‐in mouse model. The Journal of Pathology. https://doi.org/10.1002/path.70150

Vancouver

Lindholm F, West G, Virtanen L, Kähäri L, Ståhle M, Nammas W, et al. The p. Ser143Pro lamin A/C mutation leads to dilated cardiomyopathy and activates the unfolded protein response pathway in a knock‐in mouse model. The Journal of Pathology. 2026. doi:10.1002/path.70150

BibTeX
@article{Lindholm2026,
  author = {Lindholm, Fanny and West, Gun and Virtanen, Laura and Kähäri, Laura and Ståhle, Mia and Nammas, Wail and Stenvall, Carl-Gustaf A and Bouvy-Liivrand, Maria and Zhang, Fu-Ping and Sipilä, Petra and Gardberg, Maria and Toivola, Diana M and Salmi, Marko and Saraste, Antti and Rinne, Petteri and Taimen, Pekka},
  title = {The p. Ser143Pro lamin A/C mutation leads to dilated cardiomyopathy and activates the unfolded protein response pathway in a knock‐in mouse model},
  journal = {The Journal of Pathology},
  year = {2026},
  doi = {10.1002/path.70150}
}
Start for free →